Stonegate Capital Partners Initiates Coverage on NU Skin Enterprises Inc. (NUS)
NU Skin Enterprises (NYSE:NUS) received coverage initiation from Stonegate Capital Partners following strong Q2 2025 performance. The company reported revenue of $386.1M, reaching the high end of their guidance range of $355.0M-$390.0M.
Key highlights include adjusted EPS of $0.43, significantly exceeding guidance of $0.20-$0.30, and adjusted net income growth of 103.5% year-over-year. The company's gross margin expanded 106 basis points quarter-over-quarter to 68.8%. Notable segment performance included Rhyz Manufacturing's 17% revenue growth and Latin America's 107% revenue increase year-over-year.
NU Skin Enterprises (NYSE:NUS) ha visto l'avvio della copertura da parte di Stonegate Capital Partners dopo un forte Q2 2025. La società ha riportato ricavi di $386.1M, raggiungendo il limite superiore della guidance di $355.0M-$390.0M.
I punti chiave includono un utile per azione rettificato di $0.43, nettamente superiore alla guidance di $0.20-$0.30, e una crescita dell'utile netto rettificato del 103.5% su base annua. Il margine lordo si è ampliato di 106 punti base trimestre su trimestre fino al 68.8%. Tra le performance di rilievo per segmento figurano Rhyz Manufacturing con +17% di ricavi e America Latina con +107% di ricavi su base annua.
NU Skin Enterprises (NYSE:NUS) recibió el inicio de cobertura por parte de Stonegate Capital Partners tras un sólido 2T 2025. La compañía informó ingresos de $386.1M, alcanzando el extremo superior de su rango de previsión de $355.0M-$390.0M.
Entre los puntos clave destacan un BPA ajustado de $0.43, muy por encima de la guía de $0.20-$0.30, y una crecimiento del beneficio neto ajustado del 103.5% interanual. El margen bruto se amplió 106 puntos básicos trimestre a trimestre hasta 68.8%. Rendimientos notables por segmento: Rhyz Manufacturing con +17% en ingresos y América Latina con +107% en ingresos interanuales.
NU Skin Enterprises (NYSE:NUS)는 강력한 2025년 2분기 실적을 바탕으로 Stonegate Capital Partners의 커버리지 개시를 받았습니다. 회사는 매출 $386.1M을 보고했으며 지침 범위 $355.0M-$390.0M의 상단에 도달했습니다.
주요 내용으로는 지침 $0.20-$0.30를 크게 상회한 조정 EPS $0.43과 전년 동기 대비 조정 순이익 103.5% 증가가 있습니다. 분기 대비 106 베이시스포인트 확대되어 총마진 68.8%를 기록했습니다. 부문별로는 Rhyz Manufacturing의 매출 17% 증가와 라틴아메리카 매출 107% 증가가 눈에 띕니다.
NU Skin Enterprises (NYSE:NUS) a vu le lancement de sa couverture par Stonegate Capital Partners après un solide T2 2025. La société a déclaré des revenus de $386.1M, atteignant le haut de sa fourchette de prévisions de $355.0M-$390.0M.
Les points clés incluent un BPA ajusté de $0.43, bien au‑dessus de la fourchette prévue de $0.20-$0.30, et une croissance du résultat net ajusté de 103,5% en glissement annuel. La marge brute s'est élargie de 106 points de base d'un trimestre à l'autre pour atteindre 68.8%. Performances notables par segment : Rhyz Manufacturing +17% de revenus et Amérique latine +107% de revenus en glissement annuel.
NU Skin Enterprises (NYSE:NUS) erhielt eine Coverage-Aufnahme durch Stonegate Capital Partners nach einem starken Q2 2025. Das Unternehmen meldete Umsatz von $386.1M und erreichte damit das obere Ende der Prognosebandbreite von $355.0M-$390.0M.
Zu den wichtigsten Punkten zählen ein bereinigtes Ergebnis je Aktie (EPS) von $0.43, das die Prognose von $0.20-$0.30 deutlich übertraf, sowie ein bereinigtes Nettogewinnwachstum von 103,5% gegenüber dem Vorjahr. Die Bruttomarge dehnte sich quartalsübergreifend um 106 Basispunkte auf 68.8% aus. Bemerkenswerte Segmentleistungen: Rhyz Manufacturing mit 17% Umsatzwachstum und Lateinamerika mit 107% Umsatzsteigerung im Jahresvergleich.
- None.
- None.
Dallas, Texas--(Newsfile Corp. - August 8, 2025) - Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners initiates their coverage on Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj Net Income, and adj EPS of
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Q2 adj. EPS of
$0.43 exceeded guidance; adj. net income grew103.5% y/y. - Achieved net cash position ahead of schedule; Rhyz Manufacturing revenue up
17% y/y. - Latin America revenue up
107% y/y; India expansion and Prysm iO device launch on track.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261905
FAQ
What were NU Skin's (NUS) Q2 2025 earnings results?
How did NU Skin (NUS) perform compared to its Q2 2025 guidance?
What was NU Skin's (NUS) gross margin in Q2 2025?
How did NU Skin's (NUS) Latin America and Rhyz Manufacturing segments perform in Q2 2025?
What are the key growth initiatives for NU Skin (NUS) in 2025?
